Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial - Landovitz, Raphael J; Hanscom, Brett S; Clement, Meredith E; Tran, Ha V; Kallas, Esper Georges; Magnus, Manya; Sued, Omar; Sanchez, Jorge; Scott, Hyman; Eron, Joe J (Lancet HIV, 2023)